Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pancreatic Neoplasms 11Breast Neoplasms 4Disease 3Lymphoma 2Gastrointestinal Stromal Tumors 2Uveal Melanoma 1Thyroid Nodule 1Thyroid Neoplasms 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Peutz-Jeghers Syndrome 1Pancreatitis, Chronic 1Pancreatic Cyst 1Neoplasms 1Neoplasm Metastasis 1Lymphadenopathy 1Head and Neck Neoplasms 1Focus: Breast Cancer With Axillary Node Metastasis 1Fanconi Anemia, Complementation Group D1 1Esophagus 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Gemcitabine 74Capecitabine 60Paclitaxel 59Fluorouracil 58Oxaliplatin 57Bevacizumab 51Docetaxel 50Leucovorin 48Nivolumab 40Cisplatin 40Irinotecan 39Carboplatin 37Cetuximab 34pembrolizumab 32Radiosurgery 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Pemetrexed 20Doxorubicin 20Albumin-Bound Paclitaxel 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × Biopsy, Fine-Needle × Clear all
NCT01048099 2016-01-29

Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer

SCRI Development Innovations, LLC

Phase NA Completed
283 enrolled 8 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡